StockData
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. (MEDP) stock

MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$653.09+4.89 (+0.75%)

Close on Nov 17, 2026Market cap $18.27BP/E 36.2Yield –

Medpace total assets

Total assets on the balance sheet at the end of each period.

Medpace's total assets was $2.30B at Sep 30, 2026. For fiscal 2025 it was $1.98B, down 6.0% from the year before. Over ten years it grew 7.2% a year on average. The highest annual figure on record is $2.10B in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.98B-6.0%
FY2024Dec 31, 2024$2.10B+26.8%
FY2023Dec 31, 2023$1.66B+22.5%
FY2022Dec 31, 2022$1.35B-18.5%
FY2021Dec 31, 2021$1.66B+19.4%
FY2020Dec 31, 2020$1.39B+21.7%
FY2019Dec 31, 2019$1.14B+13.8%
FY2018Dec 31, 2018$1.00B+5.7%
FY2017Dec 31, 2017$950.72M-2.9%
FY2016Dec 31, 2016$979.11M-0.5%
FY2015Dec 31, 2015$984.04M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.30B+31.4%
Q2 FY2026Jun 30, 2026$2.06B+30.9%
Q1 FY2026Mar 31, 2026$2.13B+12.2%
Q4 FY2025Dec 31, 2025$1.98B-6.0%
Q3 FY2025Sep 30, 2025$1.75B-15.9%
Q2 FY2025Jun 30, 2025$1.57B-18.1%
Q1 FY2025Mar 31, 2025$1.90B+5.7%
Q4 FY2024Dec 31, 2024$2.10B+26.8%
Q3 FY2024Sep 30, 2024$2.08B+40.2%
Q2 FY2024Jun 30, 2024$1.92B+36.5%
Q1 FY2024Mar 31, 2024$1.80B+28.7%
Q4 FY2023Dec 31, 2023$1.66B+22.5%
Q3 FY2023Sep 30, 2023$1.49B+11.9%
Q2 FY2023Jun 30, 2023$1.41B+7.0%
Q1 FY2023Mar 31, 2023$1.40B+3.8%
Q4 FY2022Dec 31, 2022$1.35B-18.5%
Q3 FY2022Sep 30, 2022$1.33B-15.8%
Q2 FY2022Jun 30, 2022$1.32B-10.5%
Q1 FY2022Mar 31, 2022$1.34B-7.4%
Q4 FY2021Dec 31, 2021$1.66B+19.4%
Q3 FY2021Sep 30, 2021$1.58B+21.7%
Q2 FY2021Jun 30, 2021$1.47B+20.3%
Q1 FY2021Mar 31, 2021$1.45B+27.6%
Q4 FY2020Dec 31, 2020$1.39B+21.7%
Q3 FY2020Sep 30, 2020$1.30B+20.9%
Q2 FY2020Jun 30, 2020$1.22B+20.2%
Q1 FY2020Mar 31, 2020$1.14B+13.0%
Q4 FY2019Dec 31, 2019$1.14B+13.8%
Q3 FY2019Sep 30, 2019$1.07B+12.9%
Q2 FY2019Jun 30, 2019$1.02B+5.0%
Q1 FY2019Mar 31, 2019$1.01B+3.4%
Q4 FY2018Dec 31, 2018$1.00B+5.7%
Q3 FY2018Sep 30, 2018$949.84M+0.1%
Q2 FY2018Jun 30, 2018$968.18M+0.5%
Q1 FY2018Mar 31, 2018$973.02M+0.7%
Q4 FY2017Dec 31, 2017$950.72M-2.9%
Q3 FY2017Sep 30, 2017$948.88M–
Q2 FY2017Jun 30, 2017$963.65M–
Q1 FY2017Mar 31, 2017$966.09M–
Q4 FY2016Dec 31, 2016$979.11M–

More Medpace figures

See a number that looks wrong?